Metformin raises hydrogen sulfide tissue concentrations in various mouse organs

Pharmacological Reports

Volumn 65, Issue 3, 2013, Pages 737-742

  Wiliński, Bogdan ^a   Wiliński, Jerzy ^a   Somogyi, Eugeniusz ^a   Piotrowska, Joanna ^a   Opoka, Włodzimierz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Biguanide; Diabetes mellitus; Hydrogen sulfide; Metformin; Mice; Nitric oxide

Indexed keywords

HYDROGEN SULFIDE; METFORMIN;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DETERMINATION; DRUG DOSE INCREASE; DRUG EFFECT; FEMALE; HEART MUSCLE; KIDNEY PARENCHYMA; LIVER PARENCHYMA; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; TISSUE LEVEL;

ANIMALS; FEMALE; HYDROGEN SULFIDE; METFORMIN; MICE; TISSUE DISTRIBUTION;

EID: 84884481494     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71053-3     Document Type: Article

References (42)

1. Association AD: Standards of medical care in diabetes-2012. Diabetes Care, 2012, 35 Suppl 1, S11-63.
2. Bruno G, Landi A: Epidemiology and costs of diabetes. Transplant Proc, 2011, 43, 327-329.
3. Cleasby ME, Dzamko N, Hegarty BD, Cooney GJ, Kraegen EW, Ye JM: Metformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanisms. Diabetes, 2004, 53, 3258-3266. (Pubitemid 39564503)
4. Davis BJ, Xie Z, Viollet B, Zou MH: Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes, 2006, 55, 496-505. (Pubitemid 43343281)
5. Detaille D, Guigas B, Chauvin C, Batandier C, Fontaine E, Wiernsperger N, Leverve X: Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process. Diabetes, 2005, 54, 2179-2187. (Pubitemid 40911282)
6. Diamanti-Kandarakis E, Christakou CD, Kandaraki E, Economou FN: Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome. Eur J Endocrinol, 2010, 162, 193-212.
7. El-Mir MY, Nogueira V, Fontaine E, Averet N, Rigoulet M, Leverve X: Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem, 2000, 275, 223-228. (Pubitemid 30038975)
8. Feng X, Chen Y, Zhao J, Tang C, Jiang Z, Geng B: Hydrogen sulfide from adipose tissue is a novel insulin resistance regulator. Biochem Biophys Res Commun, 2009, 380, 153-159.
9. Gadalla MM, Snyder SH: Hydrogen sulfide as a gasotransmitter. J Neurochem, 2010, 113, 14-26.
10. Givvimani S, Munjal C, Gargoum R, Sen U, Tyagi N, Vacek JC, Tyagi SC: Hydrogen sulfide mitigates transition from compensatory hypertrophy to heart failure. J Appl Physiol, 2011, 110, 1093-1100.
11. Gupta A, Bisht B, Dey CS: Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes. Neuropharmacology, 2011, 60, 910-920.
12. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA: 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med, 2008, 359, 1577-1589.
13. Huang NL, Chiang SH, Hsueh CH, Liang YJ, Chen YJ, Lai LP: Metformin inhibits TNF-a-induced IkB kinase phosphorylation, IkB-a degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation. Int J Cardiol, 2009, 134, 169-175.
14. Ishigami M, Hiraki K, Umemura K, Ogasawara Y, Ishii K, Kimura H: A source of hydrogen sulfide and a mechanism of its release in the brain. Antioxid Redox Signal, 2009, 11, 205-214.
15. Kimura H: Hydrogen sulfide: its production, release and functions. Amino Acids, 2011, 41, 113-121.
16. Krysiak R, Gdula-Dymek A, Okopień B: Effect of metformin on selected parameters of hemostasis in fenofibrate-treated patients with impaired glucose tolerance. Pharmacol Rep, 2013, 65, 208-213.
17. Li L, Hsu A, Moore PK: Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation-a tale of three gases! Pharmacol Ther, 2009, 123, 386-400.
18. Li L, Rose P, Moore PK: Hydrogen sulfide and cell signaling. Annu Rev Pharmacol Toxicol, 2011, 51, 169-187.
19. 2S)-the third gas of interest for pharmacologists. Pharmacol Rep, 2007, 59, 4-24. (Pubitemid 46522698)
20. Manna P, Jain SK: Hydrogen sulfide and L-cysteine increase phosphatidylinositol 3,4,5-trisphosphate (PIP3) and glucose utilization by inhibiting phosphatase and tensin homolog (PTEN) protein and activating phosphoinositide 3-kinase (PI3K)/serine/threonine protein kinase (AKT)/protein kinase Cξ/λ (PKCξ/λ) in 3T3l1 adipocytes. J Biol Chem, 2011, 286, 39848-39859.
21. Ogasawara Y, Isoda S, Tanabe S: Tissue and subcellular distribution of bound and acid-labile sulfur, and the enzymic capacity for sulfide production in the rat. Biol Pharm Bull, 1994, 17, 1535-1542.
22. Owen MR, Doran E, Halestrap AP: Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J, 2000, 348, 607-614. (Pubitemid 30410251)
23. Papanas N, Maltezos E, Mikhailidis DP: Metformin and heart failure: never say never again. Expert Opin Pharmacother, 2012, 13, 1-8.
24. Patel M, Shah G: Possible role of hydrogen sulfide in insulin secretion and in development of insulin resistance. J Young Pharm, 2012, 2, 148-151.
25. Pilmore HL: Review: metformin: potential benefits and use in chronic kidney disease. Nephrology (Carlton), 2010, 15, 412-418.
26. Predmore BL, Lefer DJ: Development of hydrogen sulfide-based therapeutics for cardiovascular disease. J Cardiovasc Transl Res, 2010, 3, 487-498.
27. Predmore BL, Lefer DJ, Gojon G: Hydrogen sulfide in biochemistry and medicine. Antioxid Redox Signal, 2012, 17, 119-140.
28. Pryor HJ, Smyth JE, Quinlan PT, Halestrap AP: Evidence that the flux control coefficient of the respiratory chain is high during gluconeogenesis from lactate in hepatocytes from starved rats. Implications for the hormonal control of gluconeogenesis and action of hypoglycaemic agents. Biochem J, 1987, 247, 449-457.
29. Siegel LM: A Direct microdetermination for sulfide. Anal Biochem, 1965, 11, 126-132.
30. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV et al.: Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol, 2009, 53, 298-304.
31. Sodha NR, Clements RT, Feng J, Liu Y, Bianchi C, Horvath EM, Szabo C et al.: Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury. J Thorac Cardiovasc Surg, 2009, 138, 977-984.
32. Somogyi E, Piotrowska J, Rzeszutko W: An effect of some parameters of the determination of the hydrogen sulfide in pig liver and brain on the obtained results (Polish). Farm Prz Nauk, 2008, 5, 33-36.
33. Srebro Z, Somogyi E, Wiliński B, Góralska M, Wiliński J, Sura P: Aspirin augments the concentration of endogenous hydrogen sulfide in mouse brain and liver. Folia Med Cracov, 2006, 47, 87-91.
34. Szabo C: Roles of hydrogen sulfide in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal, 2012, 17, 68-80.
35. Taniguchi S, Niki I: Significance of hydrogen sulfide production in the pancreatic β-cell. J Pharmacol Sci, 2011, 116, 1-5.
36. Wiliński B, Wiliński J, Somogyi E, Góralska M, Piotrowska J: Paracetamol (acetaminophen) decreases hydrogen sulfide tissue concentration in brain and increases in the heart, liver and kidney in mice. Folia Biol (Kraków), 2011, 59, 41-44.
37. Wiliński B, Wiliński J, Somogyi E, Góralska M, Piotrowska J: Ramipril affects hydrogen sulfide generation in mouse liver and kidney. Folia Biol (Kraków), 2010, 34, 177-180.
38. Wiliński B, Wiliński J, Somogyi E, Piotrowska J, Góralska M: Amlodipine affects endogenous hydrogen sulfide tissue concentrations in different mouse organs. Folia Med Cracov, 2010, 1-4, 29-35.
39. Wiliński B, Wiliński J, Somogyi E, Piotrowska J, Góralska M: Atorvastatin affects the hydrogen sulfide tissue concentration in mouse kidneys and other organs. Pharmacol Rep, 2011, 63, 184-188.
40. Wiliński B, Wiliński J, Somogyi E, Piotrowska J, Góralska M: Digoxin increases hydrogen sulfide concentrations in brain, heart and kidney tissues in mice. Pharmacol Rep, 2011, 63, 1243-1247.
41. Wiliński B, Wiliński J, Somogyi E, Piotrowska J, Góralska M, Macura B: Carvedilol induces endogenous hydrogen sulfide tissue concentration changes in various mouse organs. Folia Biol (Kraków), 2011, 59, 151-155.
42. Wiliński J, Somogyi E, Góralska M, Wiliński B, Czarnecka D: Ramipril enhances the endogenous hydrogen sulfide tissue concentration in mouse heart and brain. Folia Med Cracov, 2008, 3-4, 123-130.